Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
“More of these studies are needed to make progress in…precision, or personalized, medicine,” said NCI’s Konstantin Salnikow, PhD.
But, despite the difference, the risk of dying from the disease is still small.
Researchers are learning new ways to manage common types of cancer pain, like bone pain and neuropathy pain.
Worldwide, more than 21 million new cases of cancer are predicted to occur in 2030.
An interview with researcher Mario Suvà, MD, PhD
Artificial intelligence has the potential to revolutionize cervical cancer screening, particularly in low-resource settings.
New database provides information on gene variants to clinicians, researchers and patient advocates around the world.
Researchers say the biomarker could help noninvasively diagnose precancerous lung growths and distinguish them from benign nodules.
In the United States, HPV still causes nearly 34,000 cases of cancer each year.
The new trials compare the two approaches to treating women with early-stage breast cancer with long-term follow-up.
Researchers called the results of treatment using Venclexta (venetoclax) and Vidaza (azacitidine) “remarkably impressive.”
Tafinlar (dabrafeb) plus Mekinist (trametinib) shrank tumors in people with biliary tract cancer and adenocarcinoma of the small intestine.
“It’s important to question intuitions and observational epidemiology studies, and fund large-scale trials,” said NCI’s Barry Kramer,...
The goal of developing this type of test “is to safely prevent unnecessary surgeries,” said lead investigator Yuri Nikiforov, MD, PhD.
Clinical trials are testing gel forms of oral drugs to help prevent the disease in women at an increased risk.
Researchers were able to preserve trial participants’ mental functions by avoiding the hippocampus during radiation treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.